Performance reporting through clear and timely information
Enabling better health care while creating a sustained and growing investment opportunity.
If you invest or are considering investing in TSO3, you will want to keep current with the Company’s performance and understand any fluctuations. TSO3’s online Investor Relations section keeps you up-to-date with the latest in financial reporting, including annual reports, quarterly results, and conference call webcasts. As an investment, TSO3 builds value in the health care market through rapid research prototyping. A leading innovator in low-temperature sterilization technology, TSO3 also partners with developers in creating next-generation medical devices to ensure sterilization for these devices will be viable.
|Investor News||Investor Events|
|February 14, 2018: TSO3 to Present at the RBC Capital Markets Healthcare Conference||February 22, 2018: RBC Capital Markets 2018 Healthcare Conference|
|January 25, 2018: TSO3 and Global Distributor Agree on Co-Commercial Strategy for North America||November 06, 2017: Replay the webcast Third Quarter 2017 Results|
|January 25, 2018: TSO3 Provides an Operational Update|